Table of Contents Table of Contents
Previous Page  24 / 60 Next Page
Information
Show Menu
Previous Page 24 / 60 Next Page
Page Background

212

Factores pronósticos y sobrevida a mediano

plazo de una cohorte de pacientes con cáncer

pulmonar atendidos en la red de salud de la

Universidad Católica. Período 2007-2011

Arturo Morales S.*, Carlos Calvo D.**, Sergio González B.***,

Orlando Díaz P.* y Fernando Saldías P.*

Prognostic factors and short-term survival of a cohort of adult patients with lung cancer

treated in a network of health, 2007-2011

Lung cancer is the leading cause of death from malignancy worldwide. In Chile the magnitude of

the problem and the diagnosis-associated survival are unknown.

Methods:

We examined a cohort of

202 adult patients with lung cancer histologically confirmed in a single health network between Ja-

nuary 2007 and December 2011. We accessed to medical records and images files of patients, recording

the clinical, histological, imaging and staging data. Patients were followed until December 2013 to

assess survival.

Results:

The mean age of the cohort was 68.1 ± 11.5 years, 53% were male and 86%

had a smoking history. 82.2% of the cases were symptomatic at diagnosis, been cough the symptom

most frequently reported. The predominant histological subtype was adenocarcinoma (42%), followed

by squamous cell carcinoma (26.2%). In women, adenocarcinoma was the leading histology variety

(56.4%), and in males it was adenocarcinoma (37%) and squamous cell carcinoma (33.3%). The ma-

jority of the patients were diagnosed at advanced stages of the disease. The 36-month survival rate was

46.1%. The mean survival according to clinical stage was 70.7 month in stage I, 60.3 in stage II, 47.1

in IIIA, 12.3 in IIIB and 11.7 month in stage IV. According to histological variety, the mean survival was

36.6 month in adenocarcinoma, 33.8 in squamous cell carcinoma, 20.9 in large-cell carcinoma, 11.9 in

small-cell carcinoma and 19.6 month in undifferentiated non small-cell carcinoma. There were no sig-

nificant differences in survival by age or gender.

Conclusion:

The most common histological type was

adenocarcinoma and short-term survival was related to the clinical staging and histological variants.

Key words:

Lung neoplasm, histology, neoplasm staging, prognosis, survival, outcome.

Resumen

El cáncer pulmonar es la principal causa de muerte por neoplasia a nivel mundial. En Chile se

desconoce la magnitud del problema y la sobrevida asociada al diagnóstico.

Material y Métodos:

Se

examinó una cohorte de 202 pacientes adultos con cáncer pulmonar confirmados histopatológicamente

en una red de salud entre Enero de 2007 y Diciembre de 2011. Se accedió a las fichas clínicas y ar-

chivos de imágenes de los pacientes, registrando las variables clínicas, histológicas, imagenológicas

y la etapificación clínica. Se siguió prospectivamente a los pacientes hasta Diciembre de 2013 para

determinar sobrevida.

Resultados:

La edad promedio de la cohorte fue de 68,1 ± 11,5 años, 53% eran

varones y 86% tenía historia de tabaquismo. El 82,2% de los casos presentaron síntomas al momento

del diagnóstico, siendo la tos el más frecuente. La variedad histológica preponderante fue el adeno-

carcinoma (42%), seguido del carcinoma escamoso (26,2%). En las mujeres la mayoría de los tumores

correspondieron a adenocarcinomas (56,4% del total) y en varones predominaron el adenocarcinoma

(37%) y el carcinoma escamoso (33,3%). La mayoría de los pacientes se diagnosticaron en estadios

* Departamento de Enfermedades Respiratorias, Facultad de Medicina, Pontificia Universidad Católica de Chile.

** Alumno de Medicina, Escuela de Medicina, Pontificia Universidad Católica de Chile.

***Departamento de Anatomía Patológica, Facultad de Medicina, Pontificia Universidad Católica de Chile.

Rev Chil Enf Respir 2014; 30: 212-218

trabajo original